FDA Approves Vizz, First Daily Eye Drop For Age-Related Blurry Vision
“This FDA approval represents a disruptive paradigm shift in treatment options for millions of people who are frustrated and struggling with the inevitable age-related loss of their near vision,” said Marc Bloomenstein, OD, FAAO, clinical investigator at Schwartz Laser Eye Care Center in Scottsdale, Arizona.